BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 32552404)

  • 1. Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling.
    Fish JE; Flores Suarez CP; Boudreau E; Herman AM; Gutierrez MC; Gustafson D; DiStefano PV; Cui M; Chen Z; De Ruiz KB; Schexnayder TS; Ward CS; Radovanovic I; Wythe JD
    Circ Res; 2020 Aug; 127(6):727-743. PubMed ID: 32552404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
    Nikolaev SI; Vetiska S; Bonilla X; Boudreau E; Jauhiainen S; Rezai Jahromi B; Khyzha N; DiStefano PV; Suutarinen S; Kiehl TR; Mendes Pereira V; Herman AM; Krings T; Andrade-Barazarte H; Tung T; Valiante T; Zadeh G; Tymianski M; Rauramaa T; Ylä-Herttuala S; Wythe JD; Antonarakis SE; Frösen J; Fish JE; Radovanovic I
    N Engl J Med; 2018 Jan; 378(3):250-261. PubMed ID: 29298116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mosaicism in the MAPK pathway in sporadic brain arteriovenous malformation and association with phenotype.
    Gao S; Nelson J; Weinsheimer S; Winkler EA; Rutledge C; Abla AA; Gupta N; Shieh JT; Cooke DL; Hetts SW; Tihan T; Hess CP; Ko N; Walcott BP; McCulloch CE; Lawton MT; Su H; Pawlikowska L; Kim H
    J Neurosurg; 2022 Jan; 136(1):148-155. PubMed ID: 34214981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Endothelial Hyperactivation of Oncogenic KRAS Induces Brain Arteriovenous Malformations in Mice.
    Park ES; Kim S; Huang S; Yoo JY; Körbelin J; Lee TJ; Kaur B; Dash PK; Chen PR; Kim E
    Ann Neurol; 2021 May; 89(5):926-941. PubMed ID: 33675084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS G12D or G12V Mutation in Human Brain Arteriovenous Malformations.
    Oka M; Kushamae M; Aoki T; Yamaguchi T; Kitazato K; Abekura Y; Kawamata T; Mizutani T; Miyamoto S; Takagi Y
    World Neurosurg; 2019 Jun; 126():e1365-e1373. PubMed ID: 30902772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS mutation-induced EndMT of brain arteriovenous malformation is mediated through the TGF-β/BMP-SMAD4 pathway.
    Xu H; Huo R; Li H; Jiao Y; Weng J; Wang J; Yan Z; Zhang J; Zhao S; He Q; Sun Y; Wang S; Cao Y
    Stroke Vasc Neurol; 2023 Jun; 8(3):197-206. PubMed ID: 36418055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of treatment and therapeutic targets in brain arteriovenous malformation.
    Pan P; Weinsheimer S; Cooke D; Winkler E; Abla A; Kim H; Su H
    J Cereb Blood Flow Metab; 2021 Dec; 41(12):3141-3156. PubMed ID: 34162280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mutations in intracranial arteriovenous malformations.
    Goss JA; Huang AY; Smith E; Konczyk DJ; Smits PJ; Sudduth CL; Stapleton C; Patel A; Alexandrescu S; Warman ML; Greene AK
    PLoS One; 2019; 14(12):e0226852. PubMed ID: 31891627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trametinib as a promising therapeutic option in alleviating vascular defects in an endothelial KRAS-induced mouse model.
    Nguyen HL; Boon LM; Vikkula M
    Hum Mol Genet; 2023 Jan; 32(2):276-289. PubMed ID: 35972810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAS Activating Signaling Triggers Arteriovenous Malformations.
    Cheng F; Nussinov R
    Trends Biochem Sci; 2018 Jul; 43(7):481-483. PubMed ID: 29748115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.
    Alsina-Sanchís E; García-Ibáñez Y; Figueiredo AM; Riera-Domingo C; Figueras A; Matias-Guiu X; Casanovas O; Botella LM; Pujana MA; Riera-Mestre A; Graupera M; Viñals F
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1216-1229. PubMed ID: 29449337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal miR-3131 derived from endothelial cells with KRAS mutation promotes EndMT by targeting PICK1 in brain arteriovenous malformations.
    He Q; Huo R; Wang J; Xu H; Zhao S; Zhang J; Sun Y; Jiao Y; Weng J; Zhao J; Cao Y
    CNS Neurosci Ther; 2023 May; 29(5):1312-1324. PubMed ID: 36718590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of non-hereditary brain arteriovenous malformation and therapeutic implications.
    Ota T; Komiyama M
    Interv Neuroradiol; 2020 Jun; 26(3):244-253. PubMed ID: 32024399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-ras regulates angiogenesis and vascular permeability by activation of distinct downstream effectors.
    Serban D; Leng J; Cheresh D
    Circ Res; 2008 Jun; 102(11):1350-8. PubMed ID: 18467631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations.
    Hong T; Yan Y; Li J; Radovanovic I; Ma X; Shao YW; Yu J; Ma Y; Zhang P; Ling F; Huang S; Zhang H; Wang Y
    Brain; 2019 Jan; 142(1):23-34. PubMed ID: 30544177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Basic Research for Brain Arteriovenous Malformation.
    Barbosa Do Prado L; Han C; Oh SP; Su H
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMAD4 Prevents Flow Induced Arteriovenous Malformations by Inhibiting Casein Kinase 2.
    Ola R; Künzel SH; Zhang F; Genet G; Chakraborty R; Pibouin-Fragner L; Martin K; Sessa W; Dubrac A; Eichmann A
    Circulation; 2018 Nov; 138(21):2379-2394. PubMed ID: 29976569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human model of arteriovenous malformation (AVM)-on-a-chip reproduces key disease hallmarks and enables drug testing in perfused human vessel networks.
    Soon K; Li M; Wu R; Zhou A; Khosraviani N; Turner WD; Wythe JD; Fish JE; Nunes SS
    Biomaterials; 2022 Sep; 288():121729. PubMed ID: 35999080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models.
    Chew TW; Liu XJ; Liu L; Spitsbergen JM; Gong Z; Low BC
    Oncogene; 2014 May; 33(21):2717-27. PubMed ID: 23812423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.